Carles Martínez‐Romero

Author

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Carles Martínez-Romero, Carles Martinez-Romero, Carles Martínez-Romero, Carles Martínez‐Romero

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai National Institutes of Health National Center for Advancing Translational Sciences University of Manitoba Utrecht University

About

Carles Martínez‐Romero is an author at Icahn School of Medicine at Mount Sinai specializing in virology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Immunology	6	6	882
3	Cell Biology	4	4	924
4	Allergy	1	1	22
5	Microbiology	1	1	67

Carles Martínez‐Romero

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A Kris M. White, Romel Rosales, Soner Yildiz, Science MedicineViral PathogenesisImmunologyAntiviral ResponseVirology	2021	356
Virus-induced senescence is a driver and therapeutic target in COVID-19 Soyoung Lee, Yong Yu, Jakob Trimpert, Nature Viral PersistenceAgingVirologyCellular SenescenceVirus-induced Senescence	2021	334
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs Jennifer Kouznetsova, Wei Sun, Carles Martínez‐Romero, Emerging Microbes & Infections Drug TargetEbola InfectionMedicineBioanalysisImmunology	2014	240
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry Shu Yang, Miao Xu, Emily M. Lee, Cell Discovery	2018	185
Unanchored K48-Linked Polyubiquitin Synthesized by the E3-Ubiquitin Ligase TRIM6 Stimulates the Interferon-IKKε Kinase-Mediated Antiviral Response Ricardo Rajsbaum, Gijs A. Versteeg, Sonja Schmid, Immunity ImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyE3-ubiquitin Ligase Trim6	2014	167
The Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type I Interferon Maudry Laurent-Rolle, Juliet Morrison, Ricardo Rajsbaum, Cell Host & Microbe	2014	162
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić,	2021	136
N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses Frederik Broszeit, N. Tzarum, Xueyong Zhu, Cell Reports	2019	105
Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1 Irene Ramos, Gregory R. Smith, Frederique Ruf-Zamojski, Journal of Virology	2019	103
Synergistic drug combination effectively blocks Ebola virus infection Wei Sun, Shihua He, Carles Martínez‐Romero, Antiviral Research	2016	98

Page 1